logo
Plus   Neg
Share
Email

Lipocine : U.S. Court Postpones Clarus Patent Litigation Trial Scheduled

Lipocine Inc. (LPCN) said that the U.S. District Court of Delaware has postponed the February 8, 2021 jury trial scheduled to hear arguments in patent infringement lawsuit against Clarus Therapeutics, due to the ongoing effects of the COVID-19 pandemic.

The jury trial will be rescheduled once it becomes clear when jury trials will resume in the District of Delaware.

Lipocine is alleging that Clarus's JATENZO product infringes Lipocine's U.S. patents.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is hastening its efforts to make available more at-home testing options in response to the ongoing COVID-19 pandemic. All At-Home Covid-19 Tests being used now are authorized only for emergency use, and not cleared or fully approved by the FDA. The recent granting of EUA for the Quidel Corp.'s QuickVue At-Home COVID-19 Test is one example. Dollar Tree Inc. (DLTR) Wednesday reported a profit for the fourth-quarter that climbed 309 percent from last year, while Wendy's Co. (WEN) posted a profit that grew about 46.0 percent from the prior year. Dollar Tree has increased its share repurchase authorization by $2.0 billion. Wendy's expects profit for fiscal year 2021 to be below analysts' expectations. Medical devices company Boston Scientific Corp. (BSX) agreed Wednesday to acquire the global surgical business of Israel-based Lumenis LTD from an affiliate of Baring Private Equity Asia (BPEA) for an upfront cash payment of $1.07 billion, subject to closing adjustments. Lumenis is a privately-held...
Follow RTT